| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/02/2004 | WO2004073684A2 Lipophilic drug delivery vehicle and methods of use thereof |
| 09/02/2004 | WO2004073683A1 Use of pvp-iodine liposomes for treatment of atopic dermatitis |
| 09/02/2004 | WO2004073682A2 Use of pvp-iodine liposomes for treatment of herpes |
| 09/02/2004 | WO2004073681A1 Medicaments |
| 09/02/2004 | WO2004073680A1 Ointment of droplet-dispersion type |
| 09/02/2004 | WO2004073679A1 Reinforced urethral suppository |
| 09/02/2004 | WO2004073658A2 Isoflavone derivatives |
| 09/02/2004 | WO2004073654A2 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid |
| 09/02/2004 | WO2004073652A2 Powder formulations of recombinant staphylococcal enterotoxin b (rseb) made by atmospheric spray-freeze drying for improved vaccination |
| 09/02/2004 | WO2004073645A2 Inhibition of olfatory neurosensory function of treat eating disorders and obesity |
| 09/02/2004 | WO2004073643A2 Estradiol metabolites for the treatment of pulmonary hypertension |
| 09/02/2004 | WO2004073637A2 Compositions comprising a defined polysaccharide component |
| 09/02/2004 | WO2004073636A2 Compositions comprising a polysaccharide component and one or more coating layers |
| 09/02/2004 | WO2004073635A2 Compositions comprising a plurality of particles or agglomerates having a defined particle size |
| 09/02/2004 | WO2004073632A2 Rapid absorption selective 5-ht agonist formulations |
| 09/02/2004 | WO2004073614A2 Combination therapy for the treatment of immunoinflammatory disorders |
| 09/02/2004 | WO2004073607A2 Use of steroids to treat ocular disorders |
| 09/02/2004 | WO2004073605A2 Skin peeling composition and method |
| 09/02/2004 | WO2004073597A2 Bioadhesive liquid composition which is substancially free of water |
| 09/02/2004 | WO2004073596A2 Vaccine composition comprising an hiv proteic antigen incorporated into multilamellar lipidic vesicles |
| 09/02/2004 | WO2004073592A2 Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier |
| 09/02/2004 | WO2004073584A2 Cystitis treatment with high dose chondroitin sulfate |
| 09/02/2004 | WO2004073582A2 Pearlescent film coating systems and substrates coated therewith |
| 09/02/2004 | WO2004073551A2 Transscleral drug delivery device and related methods |
| 09/02/2004 | WO2004073420A1 Compositions containing creatine, creatinine and a methyl xanthine |
| 09/02/2004 | WO2004062645B1 Microspheres containing amphotericin b |
| 09/02/2004 | WO2004062569A3 Cardiolipin compositions their methods of preparation and use |
| 09/02/2004 | WO2004062559A3 Use of microcapsules comprising an antigen for the manufacture of an ex-vivo medicament to initiate an immune response |
| 09/02/2004 | WO2004058168A3 METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS |
| 09/02/2004 | WO2004054600B1 Pharmaceutical compound containing silymarin and carbopol®, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 09/02/2004 | WO2004050057A3 An exopolysaccharides delivery system for active molecules |
| 09/02/2004 | WO2004043375A3 Pharmaceutical compositions and methods of using taxane derivatives |
| 09/02/2004 | WO2004043358A3 Formulations of low solubility bioactive agents and processes for making the same |
| 09/02/2004 | WO2004039428A3 Transdermal delivery system for dried particulate or lyophilized medications |
| 09/02/2004 | WO2004039352A3 Amorphous form of losartan potassium |
| 09/02/2004 | WO2004037187A3 Metal-containing materials, compositions and methods |
| 09/02/2004 | WO2004032881A3 Implantation of encapsulated biological materials for treating diseases |
| 09/02/2004 | WO2004030724A3 Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system |
| 09/02/2004 | WO2004017901A3 Compositions and methods for treating skin conditions |
| 09/02/2004 | WO2003101375A3 Immunostimulatory oligonucleotides and uses thereof |
| 09/02/2004 | WO2003084539A3 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 09/02/2004 | WO2003077867A3 Naltrexone hydrochloride compositions |
| 09/02/2004 | WO2003063910A3 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 09/02/2004 | WO2003032906A3 Delivery of poorly soluble drugs |
| 09/02/2004 | WO2003026617A8 (ester)-lysolecithins in liposomes |
| 09/02/2004 | WO2002072766A8 Induction of tumor immunity by variants of folate binding protein |
| 09/02/2004 | US20040172302 System and method for verifying medical device operational parameters |
| 09/02/2004 | US20040172301 Remote multi-purpose user interface for a healthcare system |
| 09/02/2004 | US20040172300 Method and system for integrating data flows |
| 09/02/2004 | US20040172222 System and method for notification and escalation of medical data |
| 09/02/2004 | US20040172169 Method and apparatus for compouding individualized dosege forms |
| 09/02/2004 | US20040172010 Apparatus and method for self-induced cough cardiopulmonary resuscitation |
| 09/02/2004 | US20040171992 Cream dispenser providing sequential dispensing means |
| 09/02/2004 | US20040171976 Medical dressing assembly and associated method of using the same |
| 09/02/2004 | US20040171828 Respiratory system disorders; asthma; antihistamines |
| 09/02/2004 | US20040171816 Humanized antibodies that recognize beta amyloid peptide |
| 09/02/2004 | US20040171815 treatment of diseases associated with amyloid deposits in the brain (pre-clinical Alzheimer's disease or Down's syndrome); genetic engineering |
| 09/02/2004 | US20040171735 Cosmetic raw materials having improved properties and processes for preparing the same |
| 09/02/2004 | US20040171687 Safe, effective; monocarboxylic acid, nonionic peroxide and inorganic monoperoxy acid salt in aqueous acidic solution |
| 09/02/2004 | US20040171684 Shelf stable verapamil hydrochloride formulations including carrier, antioxidant and chelant |
| 09/02/2004 | US20040171669 Rapid disintegration on contact with saliva forming easy to swallow palatable suspension; tablets |
| 09/02/2004 | US20040171666 Rapid, thorough absorption; eliminates gastrointestional disorder and reduces central nervous system stimulation side effects; low cost |
| 09/02/2004 | US20040171665 Novel polymorphic form IV and solvate; precipitation from ethyl acetate |
| 09/02/2004 | US20040171647 Reducing adverse side effects using optically pure S form |
| 09/02/2004 | US20040171646 Novel substituted benzimidazole dosage forms and method of using same |
| 09/02/2004 | US20040171627 quinazolinone derivatives, especially halofuginone, can also inhibit the pathophysiological processes of renal fibrosis in vivo, including the effect on both the glomeruli and the tubuli interstitial compartments |
| 09/02/2004 | US20040171609 Delivery of diazepam through an inhalation route |
| 09/02/2004 | US20040171599 Use of a pharmaceutically acceptable cellulose derivative to inhibit or reduce crystal growth of ascomycin |
| 09/02/2004 | US20040171598 administering an effective amount of a formulation free of classical preservatives and comprising a glucocorticoid; anecortave acetate |
| 09/02/2004 | US20040171597 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| 09/02/2004 | US20040171589 Differential delivery of nitric oxide |
| 09/02/2004 | US20040171584 formulations of ANGIOTENSIN II AT1 receptors antagonists, using the cyclodextrins or their derivatives, lipossomes and the biodegradable polymers; increasing the bio-availability of losartan |
| 09/02/2004 | US20040171580 Regioselectively reticulated polysaccharides |
| 09/02/2004 | US20040171572 Complex cationic lipids having quaternary nitrogens therein |
| 09/02/2004 | US20040171568 oligonucleotide at least 29 nucleotides in length, wherein the anti-HIV activity of said oligonucleotide occurs principally by a non-sequence complementary mode of action |
| 09/02/2004 | US20040171561 storage-stable mixture of a benzoyl peroxide dispersion, clindamycin or a pharmaceutically acceptable salt or ester thereof, and a pharmaceutically acceptable carrier |
| 09/02/2004 | US20040171560 antineoplastic agents such as paclitaxel, teniposide, camptothecin and derivatives thereof; preferred solvent includes absolute or dehydrated alcohol |
| 09/02/2004 | US20040171550 inhalation of the powder from an inhaler device which dispenses the correct dose of powdered polypeptide/enhancer in a particle size which maximizes deposition in the lower respiratory tract |
| 09/02/2004 | US20040171545 Plastic and elastic protein copolymers |
| 09/02/2004 | US20040171521 Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| 09/02/2004 | US20040170959 Methods for identifying antiviral oligonucleotides |
| 09/02/2004 | US20040170820 Multimetallic nanofillers with domain size less than 100 nanometers exhibiting transparency to visible light that differs by more than 20% as compared to fillers having a domain size of at least one micron. |
| 09/02/2004 | US20040170750 Edible composition and dosage form comprising an edible shell |
| 09/02/2004 | US20040170725 Edible articles that include edible optical elements and methods for producing same |
| 09/02/2004 | US20040170721 For preparing dosage forms of therapeutic agents topically effective toward the gastrointestinal tract having improved dose accuracy and uniformity |
| 09/02/2004 | US20040170713 To promote good health and as a dietary additive |
| 09/02/2004 | US20040170712 Applying a Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170711 Medical effect of Jojoba oil in the treatment of anal diseases |
| 09/02/2004 | US20040170710 Treating vaginal diseases by applying Jojoba oil extruded from Jojoba seeds |
| 09/02/2004 | US20040170707 For reducing blood cholesterol in patients |
| 09/02/2004 | US20040170704 Process for the manufacture of a herbal composition |
| 09/02/2004 | US20040170695 Melt granulated composition and modified release dosage form prepared from said composition |
| 09/02/2004 | US20040170694 Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| 09/02/2004 | US20040170693 Microcapsules |
| 09/02/2004 | US20040170691 Amoxycillin pellets |
| 09/02/2004 | US20040170690 Tablet comprising cetirizine and pseudoephedrine |
| 09/02/2004 | US20040170689 Stabilized formulations comprising hydrolytically unstable compositions |
| 09/02/2004 | US20040170688 For once a week dosing |
| 09/02/2004 | US20040170687 For prolonging the shelf life of incompatible ingredients |
| 09/02/2004 | US20040170686 Suspension vehicle for coated drug particles |